1. Home
  2. Browse Decisions
  3. A.D.3d
  4. 159 A.D.3d
  5. 159 A.D.3d 463 (2018)
 

CARINO v. PATEL

5920 301937/09.

159 A.D.3d 463 (2018)

71 N.Y.S.3d 492

2018 NY Slip Op 01538

ANTHONY CARINO et al., Appellants, v. UMANGI PATEL, M.D., Respondent, et al., Defendants.

Appellate Division of the Supreme Court of New York, First Department.

Decided March 8, 2018.

The decedent suffered from chronic myeloid leukemia, a form of cancer characterized by overproduction of white blood cells, which can be managed by use of a tyrosine kinase inhibitor (TKI) such as Gleevec, Dasatinib, or Nilotinib. Plaintiff alleges that when the decedent's liver function was found to be abnormal, defendant Dr. Patel negligently discontinued Gleevec without substituting Dasatinib or Nilotinib, thereby causing the worsening of decedent's condition and his eventual...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases